Results 11 to 20 of about 68,723 (208)
TP53 R249S mutation in hepatic organoids captures the predisposing cancer risk
The systematic approach in elucidating the gain‐of‐function (GOF) roles of TP53 mutations in early liver carcinogenesis. Unique downstream targets of TP53 L3 mutations were identified from chormatin immunoprecipitation sequencing in HCC cell lines, followed by a series of validation assays to substantiate the exclusive transcriptional regulations ...
Yin Kau Lam +10 more
wiley +1 more source
Cystic neoplasms of the pancreas are rare and constitute approximately 0.5% of all pancreatic neoplasms.The study was to describe clinicopathological features of pancreatic cystic tumors.In our retrospective study, we reviewed 10 cases of pancreatic cystic neoplasms that were diagnosed at the pathology department of Mongi Slim hospital over a 14-year ...
Limaiem, Faten +5 more
openaire +3 more sources
Endoscopic management of pancreatic cystic neoplasms. [PDF]
Pancreatic cystic neoplasms (PCNs) represent a spectrum of heterogeneous lesions with diverse biological behaviors and malignant potential. This category encompasses relatively common subtypes, such as intraductal papillary mucinous neoplasms, serous cystic neoplasms, and mucinous cystic neoplasms, alongside relatively rarer entities, including cystic ...
Zeng Y, Zhang JW, Yang J.
europepmc +3 more sources
Abstract Cystic neoplasms of the pancreas are relatively rare. This makes the evaluation and treatment of these tumors widely varied. The authors describe a patient who came to our hospital with complaints of abdominal pain, but no other related symptoms.
D J, Anderson, S, Matson
openaire +2 more sources
Management Algorithms for Pancreatic Cystic Neoplasms [PDF]
Context.— The detection of pancreatic cystic neoplasms (PCNs) has increased owing to the advancement and widespread use of imaging modalities, resulting in differences between past and current management methods for PCNs, including intraductal papillary mucinous neoplasms (IPMNs).
Hyeong Seok, Kim, Jin-Young, Jang
openaire +2 more sources
The Differential Diagnosis and Management of Pancreatic Cystic Neoplasms. [PDF]
The prevalence of pancreatic cyst lesions in the general population worldwide is 16%. The majority of these cysts are intraductal papillary mucinous neoplasms (IPMN), which are associated with a risk of developing pancreatic cancer. In this article, we summarize the current knowledge of the differential diagnosis and management of cystic pancreatic ...
Schmitz D +5 more
europepmc +4 more sources
Endoscopic Ultrasound-Guided Ablation of Focal Pancreatic Lesions: The GRUPUGE Perspective
Focal pancreatic lesions include a heterogeneous group of solid and cystic lesions, with different natures and variable clinical, imagiological, and pathological characteristics.
Miguel Bispo +6 more
doaj +1 more source
The rare case of a cystic pancreatic neuroendocrine tumor
The pancreatic neuroendocrine tumors (PanNETs) most commonly present as solid neoplasms; however, very rarely, they may present primarily as cystic neoplasms. Most of the cystic PanNETs are non-secreting tumors, and the radiological features are not well
Tarun Kumar +3 more
doaj
Serous cystic neoplasms of the pancreas are rare exocrine pancreatic neoplasms, most of which are benign and do not communicate with the pancreatic duct.
Aya Kawanishi +11 more
doaj +1 more source
Cystic fluid chromogranin A levels in different pancreatic cystic lesions
Background/Aims: Pancreatic cystic lesions have a broad spectrum of differential diagnosis. There is an ongoing demand to identify specific and sensitive cystic fluid markers for the differential diagnosis of pancreatic cysts.
Nevin Oruç +5 more
doaj +1 more source

